FPRL1 / FPR3

FPRL1 (Formyl Peptide Receptor-Like 1), now reclassified in the updated nomenclature as FPR3, is a seven-transmembrane GPCR belonging to the formyl peptide receptor family. Originally characterized as a low-affinity receptor for bacterial formylated peptides and a receptor for lipoxin A4, FPRL1 gained renewed research attention when it was identified as a functional receptor for Humanin, a mitochondria-derived peptide with potent cytoprotective and anti-apoptotic properties.

Why it matters in peptide research

FPRL1/FPR3 occupies a unique intersection between innate immune signaling and mitochondrial cytoprotection. As a pattern recognition receptor in immune cells, it mediates chemotaxis toward sites of bacterial infection and participates in the resolution of inflammation through lipoxin signaling. However, its role as a Humanin receptor has drawn broader interest from researchers focused on aging, neuroprotection, and metabolic resilience.

When Humanin engages FPRL1, it activates Gi-protein-coupled signaling that suppresses apoptotic cascades, reduces mitochondrial stress responses, and in neurons specifically, appears to block the toxic oligomerization of amyloid-beta peptides — a mechanism with potential relevance to Alzheimer's disease research. The receptor's expression on neurons, cardiomyocytes, and immune cells positions FPRL1 as a multi-tissue cytoprotective hub responsive to mitochondria-derived distress signals.

Understanding FPRL1 also matters for interpreting Humanin's pharmacology: because Humanin can signal through multiple receptor systems (including the gp130/JAK/STAT3 pathway through a trimeric receptor complex), the FPRL1-specific component represents only part of the peptide's mechanism. Dissecting receptor-specific contributions is essential for designing more selective Humanin analogues with improved therapeutic profiles.

Peptides that act on this

• Humanin — 21-amino-acid mitochondria-encoded peptide; binds FPRL1/FPR3 to exert cytoprotective effects in neurons, cardiomyocytes, and metabolic tissues; serum levels decline with age, making exogenous supplementation a subject of longevity research.
• HNG (Humanin-G) — glycine-14 substituted analogue with dramatically enhanced potency at FPRL1; used in preclinical mechanistic studies.

Common misconceptions

FPRL1/FPR3 is sometimes described as simply an "immune receptor" repurposed for a longevity peptide. This framing underestimates its biological breadth. The receptor's role in inflammation resolution (through lipoxins) and its emerging function as a mitochondrial peptide sensor suggest it is part of a conserved surveillance system linking organelle stress to whole-organism protective responses — a concept with significant implications for how the field understands mitochondria-derived peptide signaling.